VAERS Explorer
Back to explore

Report #2830509

Received Mar 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Aug 12, 2022
Onset
Aug 12, 2022
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS3UNK—
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS2UNK—
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS1UNK—

Symptoms (2)

Inappropriate schedule of product administrationProduct administered to patient of inappropriate age

Symptom narrative

with the wrong dosage schedule; vaccine with the wrong dosage schedule; Mydaughter was born; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too short in a female patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis and Men B NVS (Bexsero) for prophylaxis. On 11-AUG-2023, the patient received the 3rd dose of Bexsero. On 24-MAY-2023, the patient received the 2nd dose of Bexsero. On 12-AUG-2022, the patient received the 1st dose of Bexsero. On 12-AUG-2022, an unknown time after receiving Bexsero, Bexsero and Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Mydaughter was born). On 24-MAY-2023, the patient experienced drug dose administration interval too long (Verbatim: vaccine with the wrong dosage schedule). On 11-AUG-2023, the patient experienced drug dose administration interval too short (Verbatim: with the wrong dosage schedule). The outcome of the drug dose administration interval too short, drug dose administration interval too long and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-FEB-2025 The reporter reported that the patient was given Bexsero vaccine with wrong dosage schedule. The patient was born. She administered 1st dose on August 12, 22, the 2nd dose on May 24, 2023 and the third dose on August 11, 2023, which led to inappropriate age at vaccine administration, drug dose administration interval too long and drug dose administration interval too short. The reporter asked that had she developed enough immunity.